Gene Therapy and Coronary Artery Disease

Hellenic Journal of Cardiology

Volumn 43, Issue 6, 2002, Pages 226-235

  Antoniadis, Charalambos A ^a   Tousoulis, Dimitris ^a,b  

^a HIPPOKRATION HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Coronary artery disease; Gene therapy; Genetic vectors; Myocardial infarction

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN II ANTAGONIST; ANTIOXIDANT; ASIALOGLYCOPROTEIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA GALACTOSIDASE; CELL ADHESION MOLECULE; COMPLEMENTARY DNA; CYTOSINE DEAMINASE; FIBROBLAST GROWTH FACTOR; HIRUDIN; INTERLEUKIN 10; INTERLEUKIN 12; LIPOSOME; LOW DENSITY LIPOPROTEIN RECEPTOR; MYOD PROTEIN; NAKED DNA; NITRIC OXIDE SYNTHASE; PARVOVIRUS VECTOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN P40; RETROVIRUS VECTOR; SUPEROXIDE DISMUTASE; THYMIDINE KINASE; TISSUE PLASMINOGEN ACTIVATOR; TRANSFERRIN; VASCULOTROPIN; VIRUS DNA;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; EX VIVO STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC CODE; GERM CELL; GRAFT REJECTION; HEART INFARCTION; HUMAN; HUMAN GENOME; HYPERTENSION; IN VIVO STUDY; PARAINFLUENZA VIRUS 1; REPERFUSION INJURY; RESTENOSIS; REVIEW; SOMATIC CELL; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0842333793     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Gottschalk U and Chan S: Somatic Gene Therapy: present situation and future perspective. Arzneim-Forsch/Drug Res 1998; 48: 1111-1120.
2. st Century. Thrombosis and Haemostasis. 1997; 78(1): 605-610.
3. Finkel T and Epstein ES: Gene Therapy for Vascular Disease. FASEB J. 1995; 9: 843-851.
4. Smith CL, Eisensmith CR, Woo LS: Gene Therapy in Heart Disease. Adv Exp Med 1995; 369: 79-88.
5. Clesham JG: Gene Therapy Made Difficult. Heart 1998; 80: 313-314.
6. nd edition. Mosby publ, USA 1999; pp 283-287.
7. French AB: Gene Therapy and Cardiovascular Disease. Curr Oppin Cardiol 1998; 13: 205-213.
8. Rader DJ: Gene Therapy for Atherosclerosis. Int J Clin Lab Res 1997; 27: 35-43.
9. Li Q, Bolli R, Qiu Y, Tang XL, Murphree SS, French AB: Gene Therapy With Extracellular Superoxide Dismutase Attenuates Myocardial Stunning in Conscious Rabbits. Circulation 1998; 98: 1438-1448.
10. Chen AF, O'Brien T, Katusic ZS: Transfer and expression of recombinant nitric oxide synthase genes in the cardiovascular system. Trends Pharmacol Sci 1998; 19: 276-286.
11. Garg UC and Hassid A: Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777.
12. Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, et al: Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Prog Natl Acad Sci USA 1995; 92: 1137-1141.
13. Guzman RJ, Hirschowitz EA, Brody SL, Crystal RG, Epstein SE, Finkel T: In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA, 1994; 91: 10732-10736.
14. Huber BE, Austin EA, Richards CA, Davis ST, Good SS: Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorecal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 1994; 91: 8302-8306.
15. Murry CE, Kay MA, Bartosek T, Hausehka SD, Schwartz SM: Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. J Clin Invest 1996; 98: 2209-2217.
16. Schneider MD: Myocardial infraction as a problem of growth control: cell cycle therapy for cardiac myocytes? J Card Fail 1996; 2: 259-263.
17. Qianhong Li, Bolli R, Qiu Y, Tang XL, Murphree SS, French BA: Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation 1998; 98: 1438-1448.
18. 165 as sole therapy for myocardial ischemia. Circulation 1998; 98: 2800-2804.
19. Fromes Y, Salmon A, Wang X, Collin H, Rouche A, Hagege A, et al: Gene delivery to the myocardium by intrapericardial injection. Gene Ther 1999; 6: 683-688.
20. March KL, Woody M, Mehdi K, Zipes DP, Brantly M, Trapnell BC: Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectors. Clin Cardiol 1999; 22(suppl 1): 123-129.
21. Chen LM, Chao L, Chao J: Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats. Hum Gene Ther 1997; 8: 341-347.
22. Poston SR, Ennen M, Pollard J, Hoyt EC, Billingham EM, Robbins CR: Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allografts. J Thorac Cardiovasc Surg 1998; 116: 386-396.
23. Brauner R, Wu L, Lake H, Nonoyama M, Scholl F, Shvarts O, et al: Intracoronary gene transfer of immunosuppressive cytokines to cardiac allografts: method and efficacy of adenovirus-mediated transduction. J Thorac Cardiovasc Surg 1997; 113: 1059-1066.
24. Qin L, Chavin KD, Ding Y, Tahara H, Favaro JP, Woodward JE, et al: Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol 1995; 158: 2316-2323.
25. DeBruyne LA, Li K, Chan SY, Qin L, Bishop DK, Bromberg JS: Lipid mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses. Gene Ther 1998; 5: 1079-1087.
26. Kalo K, Shimozato O, Hoshi K, Wakimoto H, Hamada H, Yagita H, et al: Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc Natl Acad Sci USA 1996; 93: 9085-9089.
27. Hoeg MJ: Guidelines for trials of gene therapy and somatic gene therapy in cardiovascular disease. Am J Cardiol 1998; 81(8A): 60F-63F.